Carmen Bozic Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 8 hours ago
Carmen Bozic has an estimated net worth of at least $35.3 million*, as of yesterday. They own 15,337 shares of VRTX stock. They have sold 68,008 shares of VRTX stock since 2021, for an estimated $28.0 million.
Carmen Bozic $VRTX SEC Form 4 Insider Trading
Carmen Bozic has filed a total of 20 insider trades in $VRTX since 2021. Their most recent trade was a sale of 596 shares, made on Jun 26, 2026. Their largest trade was a sale of 6,988 shares, made on May 12, 2026. We estimate that they now own 15,337 shares of $VRTX, worth an estimated $7.3 million.
Insider Trading at $VRTX
There have been a total of 577 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 1,500 shares reported by Ourania Tatsis (EVP, Chief Reg. & Quality Off.), made on Jul 02, 2026.
History of Insider Stock Trades by Carmen Bozic
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 596 | Jun 26, 2026 | June 30, 2026, 4:09 p.m. |
|
VRTX
|
Sale | 1,020 | Jun 18, 2026 | June 23, 2026, 4:08 p.m. |
|
VRTX
|
Sale | 4,062 | Jun 15, 2026 | June 17, 2026, 4:12 p.m. |
|
VRTX
|
Sale | 1,745 | Jun 05, 2026 | June 9, 2026, 4:24 p.m. |
|
VRTX
|
Sale | 1,354 | May 15, 2026 | May 19, 2026, 4:04 p.m. |
|
VRTX
|
Sale | 6,988 | May 12, 2026 | May 14, 2026, 4:10 p.m. |
|
VRTX
|
Sale | 2,329 | Mar 27, 2026 | March 31, 2026, 4:10 p.m. |
|
VRTX
|
Sale | 2,329 | Feb 27, 2026 | March 3, 2026, 5:25 p.m. |
|
VRTX
|
Sale | 2,280 | Aug 07, 2024 | Aug. 8, 2024, 4:06 p.m. |
|
VRTX
|
Sale | 2,280 | Jul 24, 2024 | July 25, 2024, 4:06 p.m. |
|
VRTX
|
Sale | 2,280 | Jul 10, 2024 | July 12, 2024, 4:07 p.m. |
|
VRTX
|
Sale | 2,280 | Jun 26, 2024 | June 28, 2024, 4:04 p.m. |
|
VRTX
|
Sale | 2,280 | Jun 12, 2024 | June 13, 2024, 4:11 p.m. |
|
VRTX
|
Sale | 2,280 | May 29, 2024 | May 31, 2024, 4:19 p.m. |
|
VRTX
|
Sale | 5,650 | Nov 14, 2023 | Nov. 16, 2023, 5:15 p.m. |
|
VRTX
|
Sale | 5,651 | Oct 31, 2023 | Nov. 2, 2023, 4:07 p.m. |
|
VRTX
|
Sale | 5,651 | Oct 17, 2023 | Oct. 19, 2023, 4:18 p.m. |
|
VRTX
|
Sale | 5,651 | Oct 03, 2023 | Oct. 5, 2023, 4:30 p.m. |
|
VRTX
|
Sale | 5,651 | Sep 19, 2023 | Sept. 21, 2023, 4:15 p.m. |
|
VRTX
|
Sale | 5,651 | Sep 05, 2023 | Sept. 7, 2023, 4:29 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Stuart A Arbuckle, EVP, COO
-
Jeffrey M Leiden, Executive Chairman
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Carmen Bozic, EVP and CMO
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
-
Joy Liu, EVP and Chief Legal Officer
-
Duncan Mckechnie, EVP, Chief Commercial Officer
-
Mark E. Bunnage, EVP, Chief Scientific Officer
-
Amit Sachdev, EVP, Chief Patient Officer
-
Charles F Jr Wagner, EVP, CO & FO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.